Goal-directed vs. Empirical Tranexamic Acid Administrationin Cardiovascular Surgery
Summary
The present study is a multi-center randomized prospective placebo-controlled non-inferiority trial. The study's primary objective is to compare the amounts of postoperative bleeding using two different TXA administration strategies: empirical TXA administration vs. viscoelastic test-based goal-directed TXA administration in cardiovascular surgery. The secondary objectives include comparing the incidents of hyper-fibrinolysis, thromboembolic complications, and postoperative seizures. Researchers assumed that goal-directed tranexamic acid (TXA) administration using viscoelastic field tests would not be inferior to the empirical TXA administration strategy in reducing postoperative bleeding and hyper-fibrinolysis. It also would be beneficial in lowering TXA-induced thromboembolic complications and seizures.
Timeline
- Start
- 2023-08-01
- Primary completion
- 2025-04-30
- Completion
- 2025-06-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Tranexamic Acid | Small molecule | 2 mg/kg | Intravenous |
| Subject | Tranexamic Acid | Small molecule | 10 mg/kg | Intravenous |
| Subject | Tranexamic Acid | Small molecule | 20 mg/kg | Intravenous |